Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression.
about
Toll-like receptor 9 in breast cancer.DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cellsTumor infiltrating CD8(+) T lymphocyte count is independent of tumor TLR9 status in treatment naïve triple negative breast cancer and renal cell carcinomaCombination of meta-analysis and graph clustering to identify prognostic markers of ESCCRegulation of migration and invasion by Toll-like receptor-9 signaling network in prostate cancer.Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue.Nucleic acid-sensing toll-like receptors 3, 7 and 8 in esophageal epithelium, barrett's esophagus, dysplasia and adenocarcinomaWhole blood expression profiling from the TREAT trial: insights for the pathogenesis of polyarticular juvenile idiopathic arthritisToll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett's esophagus, dysplasia and adenocarcinomaBiopathological Significance of TLR9 Expression in Cancer Cells and Tumor Microenvironment Across Invasive Breast Carcinomas Subtypes.Toll-like receptors in esophageal cancer.Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue.Toll-like receptor 9 expression in mucoepidermoid salivary gland carcinoma may associate with good prognosis.Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer.Immunohistochemical expression of TLR4 and TLR9 in various grades of oral epithelial dysplasia and squamous cell carcinoma, and their roles in tumor progression: a pilot study.Toll-like receptor 5 and the emerging role of bacteria in carcinogenesis.The Discovery and Validation of Biomarkers for the Diagnosis of Esophageal Squamous Dysplasia and Squamous Cell Carcinoma.Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancerIncreased Toll-like receptor 5 expression indicates esophageal columnar dysplasia.TLR9 signaling activation at different stages in colorectal cancer and NF-kappaB expression
P2860
Q33928402-9121052B-9E6C-4FA1-A94E-132024FF1BC4Q34549200-BBC76051-5FC6-4997-BCC4-50B9AB9BDB61Q35798941-55406127-C462-4D1A-A8AA-882ED77F14D6Q36075628-A23708E2-A38E-4093-8460-FF533333E59FQ36356021-4CD90B29-9D36-4A4B-911E-E8C33CACFD01Q36671862-B294E3E7-89E3-4147-936E-B4B972B570E2Q37012686-FCA39A90-9E66-44FA-878F-8A447F7D3230Q37073220-ED93D569-81B1-4575-8F52-09663F68EE77Q37269094-C6102FA5-B5FF-41CC-A795-F4142646975CQ37605221-184D2763-E0FB-4D69-8333-D4DD61F64698Q38213392-6B3E8031-3E77-4CB5-9055-92DA99684129Q38945757-C9F19924-74B8-4806-ADB8-06882C0D2FA4Q39028490-1AB52A90-FF4F-45D9-8F14-B7ED07306D01Q39305431-AB6962AD-EE25-4750-AA43-610BB379CAAAQ39423531-6DCC949B-DC88-4120-8C6A-2371C2CA14C9Q40725192-FD6CC234-1A26-4BAC-8711-493FD2160C09Q40803468-DAE39282-AF9E-4CA2-AC73-01ECE0417209Q41497232-36504C3E-FAAB-4E75-900B-977070BCB548Q42149484-0F804261-DFF8-4D8F-828C-E26814120C44Q42448630-11AD661A-8115-47D9-A1FA-DFD774AE1F4FQ57073978-55E1E463-846D-4C03-91B0-E484A3DB17ED
P2860
Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Toll-like receptor 9 is a nove ...... us cell carcinoma progression.
@en
Toll-like receptor 9 is a nove ...... us cell carcinoma progression.
@nl
type
label
Toll-like receptor 9 is a nove ...... us cell carcinoma progression.
@en
Toll-like receptor 9 is a nove ...... us cell carcinoma progression.
@nl
prefLabel
Toll-like receptor 9 is a nove ...... us cell carcinoma progression.
@en
Toll-like receptor 9 is a nove ...... us cell carcinoma progression.
@nl
P2093
P2860
P356
P1476
Toll-like receptor 9 is a nove ...... us cell carcinoma progression.
@en
P2093
Heikki Takala
Joonas H Kauppila
Juha Saarnio
Katri S Selander
Katri S Vuopala
Tuomo J Karttunen
P2860
P304
P356
10.1159/000329115
P577
2011-08-29T00:00:00Z